Cover Image

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ

Cysteinyl leukotriene receptor 1 antagonists (CysLT1RA) are frequently used as add-on medication for the treatment of asthma. Recently, these compounds have shown protective effects in cardiovascular diseases. This prompted us to investigate their influence on soluble epoxide hydrolase (sEH) and per...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tamara Göbel (Author), Olaf Diehl (Author), Jan Heering (Author), Daniel Merk (Author), Carlo Angioni (Author), Sandra K. Wittmann (Author), Estel.la Buscato (Author), Ramona Kottke (Author), Lilia Weizel (Author), Tim Schader (Author), Thorsten J. Maier (Author), Gerd Geisslinger (Author), Manfred Schubert-Zsilavecz (Author), Dieter Steinhilber (Author), Ewgenij Proschak (Author), Astrid S. Kahnt (Author)
Format:	Book
Published:	Frontiers Media S.A., 2019-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
by: Brandes Ralf P, et al.
Published: (2011)

Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019)

Pharmacological plasticity-How do you hit a moving target?
by: Michael J. Parnham, et al.
Published: (2019)

Soluble epoxide hydrolase in the human placenta throughout gestation
by: Tai-Ho Hung, et al.
Published: (2019)

Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017)

The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
by: John D. Imig, et al.
Published: (2020)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
by: Bomina Park, et al.
Published: (2019)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019)

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
by: Kenji Hashimoto
Published: (2019)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
by: Astrid S. Kahnt, et al.
Published: (2022)

Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
by: Karen M. Wagner, et al.
Published: (2021)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
by: Shan Jiang, et al.
Published: (2024)

Detoxication Strategy of Epoxide Hydrolase-The Basis for a Novel Threshold for Definable Genotoxic Carcinogens
by: Franz Oesch, et al.
Published: (2004)

Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy
by: Chin-Wei Chiang, et al.
Published: (2015)

Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of Ulmus davidiana var. japonica
by: Jang Hoon Kim, et al.
Published: (2021)

Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
by: Qian Ren, et al.
Published: (2019)

Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
by: Xiayun Wan, et al.
Published: (2020)

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
by: Victor Samokhvalov, et al.
Published: (2019)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
by: Fangyu Du, et al.
Published: (2022)

Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis
by: Tai-Ho Hung, et al.
Published: (2019)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
by: Juan Martín-López, et al.
Published: (2021)

Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis
by: Ryan D. Jones, et al.
Published: (2019)

Fluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy
by: Vladimir V. Burmistrov, et al.
Published: (2023)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023)

Unraveling the Pharmacological Potential of Lichen Extracts in the Context of Cancer and Inflammation With a Broad Screening Approach
by: Rebecca Ingelfinger, et al.
Published: (2020)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
by: Nils Helge Schebb, et al.
Published: (2022)

Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase
by: Cai Yi Wang, et al.
Published: (2019)

Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes
by: Rohit Pardeshi, et al.
Published: (2019)

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
by: Sean Shaw, et al.
Published: (2009)

Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway
by: Yue Yu, et al.
Published: (2023)

CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop
by: Yihui Chen, et al.
Published: (2022)

Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice
by: Kristen L Zuloaga, et al.
Published: (2015)

A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models
by: Júlia Jarne-Ferrer, et al.
Published: (2022)

The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway
by: Na Dai, et al.
Published: (2020)

Insights into the inhibitory activities of neolignans and diarylnonanoid derivatives from nutmeg (Myristica fragrans Houtt.) seeds on soluble epoxide hydrolase using in vitro and in silico approaches
by: Vu Thi Oanh, et al.
Published: (2023)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
by: Debin Wan, et al.
Published: (2019)

Multi-Target Approaches in Metabolic Syndrome
by: Felix F. Lillich, et al.
Published: (2021)

Zafirlukast in combination with pseudohypericin attenuates spinal cord injury and motor function in experimental mice
by: Chen XG, et al.
Published: (2018)